AccuStem Sciences, Inc.
ACUT
$0.16
-$0.07-28.89%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -16.13% | -7.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.76% | -5.54% | |||
| Operating Income | 48.01% | 5.54% | |||
| Income Before Tax | 48.01% | 5.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 48.01% | 5.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 48.01% | 5.54% | |||
| EBIT | 48.01% | 5.54% | |||
| EBITDA | 48.02% | 5.56% | |||
| EPS Basic | 48.01% | 5.63% | |||
| Normalized Basic EPS | 48.15% | 5.50% | |||
| EPS Diluted | 48.01% | 5.63% | |||
| Normalized Diluted EPS | 48.15% | 5.50% | |||
| Average Basic Shares Outstanding | 0.00% | -0.06% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||